Cyclacel's SecondGeneration CDK29 Inhibitor CYC065 Demonstrates Therapeutic Potential and Synergy With Other AntiCancer Compounds

Press/Media: Press / Media

PeriodApr 20 2015

Media coverage

1

Media coverage

  • TitleCyclacel's SecondGeneration CDK29 Inhibitor CYC065 Demonstrates Therapeutic Potential and Synergy With Other AntiCancer Compounds
    Media name/outletBioPortfolio
    CountryUnited Kingdom
    Date4/20/15
    PersonsJing Wang